Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.
about
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeThe next generation: fluoroquinolones in the management of acute lower respiratory infection in adultsIn vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season.Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaPrevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in KoreaIn vitro activity and rodent efficacy of clinafloxacin for bovine and swine respiratory disease.Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones.In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.Grepafloxacin, a dimethyl derivative of ciprofloxacin, acts preferentially through gyrase in Streptococcus pneumoniae: role of the C-5 group in target specificity.Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniaeTopoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin.Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions.
P2860
Q33594174-D1E657CE-59C2-4090-A562-50AC725A7F5CQ33715260-4E6F3B68-D73D-40AA-8C8B-61DA87A67DCCQ33801878-3C4A52D5-FD8E-416F-A0B2-4AC84D8113DAQ33977709-FE92A41B-817A-40A0-B835-9E69045B981FQ33979508-F49D4AC8-1B8F-4B19-B897-3D6C47E7CA8CQ33983092-4B0C3717-0D9C-478E-8286-2DC8ED1AA563Q34647294-42B90966-6E82-4B3B-86E5-BFBEB7E0FE81Q35879084-AB3AC96E-93FA-40BE-99DE-435C56BB4881Q36927802-4EFD5EC2-6BB1-4F05-8C3A-7402E8A7BDCCQ37121180-1585B400-464D-49CC-97E0-49E6ECC38C45Q39471518-69750858-ED1E-4A69-9890-D7F7FD7A3A6AQ39475328-48BD5B32-DCFA-4930-A8E4-07E8B9D72815Q39651301-E1FE237B-DF5C-4A2D-8F4D-0C44006BBD68Q39652951-78A166A6-9191-4B03-B307-76BDE7367583Q39652979-0E9D5CF4-1863-4902-AD00-8E409A313D1BQ39653038-8F2C96CA-22CD-46FE-8501-3B565CACEB47Q40621873-0B1F4B55-2AF8-4976-88F5-ED7B1A0BB582Q41071899-0B5612AF-5123-4495-A420-47E828C8A9AAQ42273994-857BCCBB-D2C7-49B7-9D46-3576CC60052EQ42844652-27F8EAA0-B97C-44E2-88C7-483C4E3CF279Q43014021-B4184A6F-7A17-4FD6-88F8-F25D5D3F3A44Q43181777-50361B28-0448-4F89-9559-3F88D27817C8Q47195199-EB926DE5-13B3-4900-BCE2-5414A6EA649C
P2860
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Activities of new fluoroquinol ...... f the lower respiratory tract.
@en
Activities of new fluoroquinol ...... f the lower respiratory tract.
@nl
type
label
Activities of new fluoroquinol ...... f the lower respiratory tract.
@en
Activities of new fluoroquinol ...... f the lower respiratory tract.
@nl
prefLabel
Activities of new fluoroquinol ...... f the lower respiratory tract.
@en
Activities of new fluoroquinol ...... f the lower respiratory tract.
@nl
P2860
P356
P1476
Activities of new fluoroquinol ...... of the lower respiratory tract
@en
P2093
P2860
P304
P356
10.1128/AAC.42.11.2956
P407
P577
1998-11-01T00:00:00Z